What is Evergreen Nephrology?
Evergreen Nephrology is dedicated to simplifying kidney care by fostering close collaborations among patients, nephrologists, and primary care physicians to elevate health outcomes. The company champions value-based care models, equipping healthcare providers with essential resources and data-driven insights to deliver personalized and effective treatments. By actively working to dismantle barriers to care, Evergreen Nephrology ensures patients receive comprehensive support for managing their kidney health. Their integrated strategy benefits patients, physicians, and payors alike, aiming to substantially improve the quality of chronic kidney disease management.
How much funding has Evergreen Nephrology raised?
Evergreen Nephrology has raised a total of $130M across 1 funding round:
Other Financing Round
$130M
Other Financing Round (2025): $130M with participation from Oak HC/FT, K2 HealthVentures, and Rubicon
Key Investors in Evergreen Nephrology
Oak HC/FT
Oak HC/FT is a prominent venture growth-equity fund that invests in Healthcare Information & Services and Financial Services Technology. With substantial assets under management, they focus on driving industry transformation through strategic counsel and network access.
K2 HealthVentures
K2 HealthVentures is an alternative investment firm providing flexible, long-term financing to life sciences and healthcare companies. They offer creative financing solutions and aim to fuel growth in innovative companies while supporting underserved areas in healthcare.
Rubicon
Rubicon is a technology company focused on waste management and recycling solutions, utilizing software platforms and data analytics to optimize operations and promote sustainability. They aim to transform the waste industry through technology-enabled services.
What's next for Evergreen Nephrology?
With this substantial enterprise-level backing, Evergreen Nephrology is poised for accelerated growth and expanded service offerings. The strategic investment signals confidence in their value-based care model and their capacity to drive innovation in nephrology. Future initiatives will likely focus on scaling their technology platform, enhancing data analytics capabilities for predictive care, and broadening their network of physician partnerships. This capital infusion will empower Evergreen Nephrology to further its mission of improving kidney disease outcomes and solidifying its position as a leader in patient-centric renal care.
See full Evergreen Nephrology company page
